$RGNX 8-K SEC Filings

Filed On	Filing
16 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers On October 14, 2026, Kenneth T. Mills resigned from the board of directors (the “Board”) of REGENXBIO Inc. (the “Company”) effective October 21, 2026. Mr. Mills recently became chief executive officer of another company and intends to fo...
23 Sep 2026	8-K: Entry into a Material Definitive Agreement On September 23, 2026, REGENXBIO Inc. (the “Company”) and The Trustees of the University of Pennsylvania (“UPenn”) entered into a Settlement Agreement (the “Settlement Agreement”) with Sarepta Therapeutics, Inc. and Sarepta Therapeutics ...
25 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation
24 Aug 2026	8-K: Regulation FD Disclosure; Other Events
06 Aug 2026	8-K: Results of Operations and Financial Condition
20 Jul 2026	8-K: Other Events
29 Jun 2026	8-K: Other Events
03 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders; Other Events
14 May 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
20 Mar 2026	8-K: Entry into a Material Definitive Agreement
05 Mar 2026	8-K: Results of Operations and Financial Condition
10 Feb 2026	8-K: Regulation FD Disclosure; Other Events
28 Jan 2026	8-K: Other Events
06 Nov 2025	8-K: Results of Operations and Financial Condition
18 Aug 2025	8-K: Other Events
07 Aug 2025	8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +1 more
03 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
19 May 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
12 May 2025	8-K: Results of Operations and Financial Condition
13 Mar 2025	8-K: Results of Operations and Financial Condition

Comments